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Excessive and inappropriate use of medications, or ‘polypharmacy’, has been recognized as a
public health problem. In addition, there is growing use of dietary supplements in the United
States; however, little is known about the patterns of supplement use. Recent reports in the
literature of cases of excessive or inappropriate use of herbal dietary supplements leading to the
term ‘polyherbacy’. The clinical vignettes described in this article highlight the need for further
research on the nature and extent of multiple and inappropriate dietary supplement use or
‘dietary supplement polypharmacy’. Clinical interviewing and population surveys both address
this issue in complementary ways, and provide a further understanding of dietary supplement
use patterns.
Keywords: complementary and alternative medicine–dietary supplements–drug interactions–
herbals–polypharmacy
Introduction
Excessive and inappropriate use of medications has been
recognized as a public health problem, resulting in an
increased likelihood of adverse drug events, drug inter-
actions, and inappropriate drug prescribing and increased
costs (1). Multiple strategies have been developed to
contain and recognize this problem, also known as
polypharmacy. In addition, there is growing use of
dietary supplements in the United States, with sales for
the year of 2006 estimated at over $21 billion (2).
However, little is known about the patterns of dietary
supplement use or how they interact with medications,
although population surveys are addressing this issue
(3–7). There are recent reports in the literature of cases of
excessive or inappropriate use of herbal dietary supple-
ments, leading to the term ‘polyherbacy’ (8) implying at
least potential similarity to the health problems asso-
ciated with polypharmacy.
Dietary Supplements were defined by the Dietary
Supplement Health and Education Act of 1994 as a
product taken orally, and intended to supplement the
diet. Dietary supplements include vitamins, minerals,
herbs and other botanicals, amino acids, and substances
such as enzymes, organ tissues, glandulars and metabo-
lites. The Food and Drug Administration (FDA)
regulates dietary supplements differently than prescrip-
tion and over-the-counter drugs. Dietary supplement
manufacturers are not required by the FDA to prove
safety or efficacy and are not required to follow
established drug product good manufacturing practices
(GMPs), although dietary supplement-specific GMPs are
being developed by the FDA (9). In December 2006,
the Dietary Supplement and Nonprescription Drug
Consumer Protection Act (10) was signed into law,
requiring the FDA to establish systems of data collection
on serious adverse reactions that people experience while
using dietary supplements. Manufacturers and distribu-
tors of dietary supplements are now required by law to
submit information to the FDA concerning adverse
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properly cited.reactions reported to them by the public. This new
regulatory requirement begins to address long recognized
safety concerns over dietary supplement use.
Population surveys can provide substantial insight into
the magnitude of herbal or dietary supplement use in the
US National surveys published recently documented use
of dietary supplements ranging from 19% to 65% (3,6).
However, published surveys may not be fully informative
on patterns or extent of individual dietary supplement
use, including multiple or excessive supplement use,
appropriateness of use in accordance with evidence-
based indications, or combinations of herbs with other
supplements or medications. In part, this is due to
limitations in the standardization of products and
product names, the ubiquity of multi-ingredient prepara-
tions and the lack of assessment of changing use patterns
over time. To our knowledge, there are no databases in
the US of dietary supplement labels and detailed product
information. The Office of the Director, Office of Dietary
Supplements (ODS), National Institutes of Health has
recently announced that it is seeking to partner with
industry and academic institutions to develop such a
database (11).
One complementary approach to population surveys is
the qualitative study of representative individual case
histories derived from a clinical setting, to better
characterize individual patterns of use. In this report,
we describe four cases illustrating examples of dietary
supplement polypharmacy, which are derived from a
Complementary and Alternative Medicine Clinic
(CAMC) located in a large Midwestern academic medical
center.
Methods
The authors reviewed 150 case records of University
of Iowa CAMC to select illustrative cases of dietary
supplement polypharmacy occurring between September
2003 and September 2005. The cases selected below were
chosen to provide significant illustrations of commonly
reoccurring themes. They were selected based on the
completeness of the medical record and illustrative
potential. The CAMC can serve as an important setting
to observe and document the behavior of individuals
who use CAM, and dietary supplements in particular.
It is a consultative service, housed in a large teaching
hospital, in the Department of Internal Medicine.
The majority of patients access the CAMC through
self-referral, but roughly onethird of new patients are
referred by a physician or other health care professional.
Most physician referrals are related to concerns over
dietary supplement use, potential dietary supplement-
drug interactions and dietary supplement polypharmacy.
Nearly all CAMC patients are English-speaking and age
18 years or older; the CAMC serves nearly 600 patients
per year. CAMC appointments are lengthy, often lasting
60–120min for new patients with extensive dietary
supplement use. Nearly all CAMC patients share a
strong interest in CAM use. While not all patients use
dietary supplements, the majority use at least one
supplement, with the average patient using three to five
dietary supplement products, typically containing multi-
ple active ingredients.
Clinic appointments involve a detailed dietary supple-
ment use history, with direct validation via inspection of
original product containers and labels by a physician or
pharmacist. All patients are asked to bring their dietary
supplements original containers to aid in identification.
Initially, the comprehensive list of current and past
supplement use was recorded manually on a form and
incorporated into the medical record. Manufacturers’
information and Internet web sites were used to aid in
identifying product constituents. As electronic record-
keeping was implemented, dietary supplement informa-
tion was progressively incorporated into the electronic
medical records. In September 2003, a computerized
dietary supplement form was introduced, allowing
patients or health professionals to enter the names,
constituents, brand, dose, frequency of use, purpose and
cost of each dietary supplement used. When patients
performed the entry, the evaluating physician or phar-
macist would later validate that data.
Results
Selected Case Histories Illustrative of Dietary
Supplement Polypharmacy
The following are illustrative case histories of commonly
observed behavioral patterns with respect to dietary
supplement polypharmacy.
Case 1—The Liver Function Abnormality Mystery:
Consider Supplements!
A 54-year-old woman with a history of large goiter and
liver function abnormalities was referred by her physician
to the CAMC to address her multiple dietary supplement
use. She was noted to have moderate liver function
abnormalities (ALT 3 times normal range) during a
medical evaluation. After extensive evaluation of her liver
dysfunction no apparent causes were found. She did not
drink alcohol or take any medications, and was of
normal body weight. Infectious, obstructive and auto-
immune causes were ruled out. She was noted to consume
a number of dietary supplements and referred to our
clinic to address dietary supplement polyherbacy and its
potential affect on her liver function tests. She brought
all her supplements for review. At that evaluation,
we addressed the purpose of her use of each supplement
(Table 1).
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ments over the years, as she read extensively and
frequently researched the internet for information on
these products. Ultimately she felt at a loss as to which
supplements might be of benefit or which supplements to
stop taking. This patient typically would use less than the
recommended dose noted on the label, but at times would
use a higher than recommended dose. She also would
vary which supplement she might use in any given day.
She expressed concern that her dietary supplement
intake had gotten out of control and felt she may be
addicted to using supplements as they gave her a greater
sense of control.
After discussing the purpose for using each dietary
supplement and concerns with dietary supplement poly-
pharmacy and its potential effect on her liver dysfunc-
tion, she agreed to stop all supplements for the time
being, with the exception of calcium and vitamin D, and
one multivitamin a day. Until her follow-up visit she
would increase her dietary intake of antioxidant foods,
acidophilus and omega 3 fatty acids in place of her
supplements, and practice mind-body techniques and
exercise for health and stress reduction. We also offered a
referral to counseling for anxiety management. Follow-up
liver function tests were normal. We proposed to
re-introduce a fewer number of supplements, based on
evidence-based indications and safe dose ranges, one at a
time, while we followed her liver function tests. She
elected however to stay off the supplements over the next
two follow-up visits, as she was happy with her dietary
modifications. Based on the evidence presented above,
we believe that her abnormal liver function tests were
a result of excessive supplement use and resolved
completely with withdrawal of offending agents.
Comment
Following principles applicable to the management of
polypharmacy, we recommended stopping all unnecessary
supplements. Except for the calcium and vitamin D, none
of her supplements were deemed essential, her pattern
of use was erratic and she was unsure of benefits.
By agreeing to guide her on the reintroduction of the
dietary supplements once her liver function tests normal-
ized, we provided a framework of partnership and
respect. Nondietary supplement options were recom-
mended to address her need for control and to manage
her anxiety.
Case 2—Challenges from Different World Views: Intuitive
Choice and Dietary Supplement Polypharmacy
A 56-year-old female was self-referred to the CAMC and
brought a lengthy list of dietary supplements. She used
different supplements each day and often would not
follow the recommended doses in the bottles. An extremely
important dimension of this patient’s behavior was the
method she used in selecting, which supplements she would
use: The patient would choose the supplement to be used at
a particular time by holding her fingers over the supple-
ment container and allow the use of ‘energy’ or ‘muscle
strength’ to guide her. If she felt her fingers stronger, the
supplement would be chosen. This she called ‘applied
kinesiology’, which was often utilized by the alternative
health providers whom she had consulted with.
Table 1. Dietary supplements and purpose of use
Dietary supplements Purpose of use
Algae: multiple products containing Blue-green algae,
Chlorella, Spirulina and Norwegian kelp
Thyroid health, goiter, iodine source
Allergy multi (Multivitamin complex for chemically sensitive individuals)
and other individual supplements in addition to her multivitamin product:
B complex, ester C, vitamin D, vitamin E, vitamin K, selenium
Vitamins and minerals
Boron, three different calcium preparations, two different magnesium
preparations and silica
Bone density
Carotenoid complex: 25000IU plus lutein, lycopene, alpha-carotene,
alpha-lipoic acid, Antartic krill, broccoli concentrate, pumpkin
concentrate, carrot seed oil
Eye health, other
Digestive enzyme formula (two different kinds), probiotics
(two different kinds)
Digestion
Oils: Black currant, Evening primrose, organic flax Beneficial oils
Glucosamine and chondroitin sulfate Joint health
Siberian Ginseng Energy
Ginkgo Biloba Memory
Echinacea (angustifolia and purpurea) Colds and infection
Valerian extract Sleep, occasional use
Turmeric Cancer prevention, inflammation
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identity and the dose being chosen and was unable to
report which of the supplements or doses she used
regularly. The total number of supplements used could
not be estimated after multiple visits with a physician and
pharmacist. A summary of her regimen occupied 17 pages.
A selection of her supplements is listed in Table 2.
Of note, the practices described in this case are not
intended to be representative of the complementary
medicine technique ‘Applied Kinesiology’ (12,13),
described at the International College of Applied
Kinesiology web site as a complex technique to be used
only by trained licensed providers, in conjunction with
standard diagnostic methods.
It is also important to note that the diagnoses or
medical problems noted in Table 2, were primarily self-
diagnoses or diagnosis given to her by nonallopathic
providers. She had known gallstones.
Comment
This is a striking example of dietary supplement
polypharmacy. The use of ‘energy guidance’ and
‘muscle strength testing’, which she described as ‘applied
kinesiology’, in her choice of supplement used could be
considered very unusual by many health care profes-
sionals. However, variations of each approach are uti-
lized by some alternative medicine providers and patients
alike. Providers and patients will test the patient using
applied kinesiology to determine current therapeutic
needs. Based on these testing, dietary supplements are
then recommended and often also sold to the patient by
that provider. This form of dietary supplement use poses
a potential safety challenge, as it does not involve scien-
tific knowledge on potential benefits, drug interactions or
side-effects for the dietary supplement used. Furthermore,
it creates a challenge in the potential identification of
side-effects, drug interactions, or benefits, as the user may
not be able to describe what regimen they are using on a
particular day. Another dimension of the problem is that
some alternative healers may instruct the patient to stop
a prescribed medication, felt to be potentially harmful,
based on ‘muscle strength testing’ or financially exploit a
vulnerable individual, compelling the patient to purchase
a supplement sold by the healer, presented as essential to
balance one’s energy.
Case 3—The Case of the Dependent Adult at Risk
An 83-year-old widowed man with a diagnosis of
dementia, was brought to the CAMC by his two daughters
to establish care, as he had just moved in from Florida.
His daughters were the decision makers in his care and
disagreed upon which course to take, thus the consultation
to our clinic. His medical history includes two recent
strokes, early dementia, and the use of multiple dietary
supplements and warfarin. Despite recurrent strokes on
aspirin and an antiplatelet aggregation agent (Ticlopidine),
one of his daughters wished to stop his warfarin against
medical advice and rely on the use of complementary
therapies to prevent further strokes. She believed that the
oral chelation therapy he had received by an alternative
health care provider while living in Florida should have
eliminated his thromboembolic risk. She felt that war-
farin—which she described as a ‘rat poison’—was detri-
mental for his health. Another daughter was concerned
with potential complications such as recurrent stroke, if he
stopped the prescribed agents. The patient deferred the
decision to his daughters. As there was significant family
disagreement on how to proceed, they presented for
a consultation to our CAMC. He has not yet established
care with a primary care provider.
Medications taken by the patient included Warfarin
and Simvastatin (Table 3).
Comment
This case illustrates three complex medical issues. The
first problem pertains to the increased risk for adverse
Table 2. Dietary supplements and purpose of use
Dietary supplements Purpose of use
Thirty-four Homeopathic products (12). Examples of such remedies
used includes: Arsenicum ALB., Aconitum NAP, Calcarea carbonica,
Collisonia CAN., Gelsemium SEMP., Ignatia Amarra, Natrum
Muriaticum, Nux Vomica, Phosphoricum Acidum, Plumbum Metalicum,
Rhus Tox. Stramonium, Thuja Occid
Multiple ailments, as dictated by energy or divine guidance
Botanical agents included: Chanca piedra, Bladderwrack, Cat’s claw,
Chaste tree berry, Ginseng, Gingko, Grapefruit seed extract, Hawthorn,
Horsetail, Olive Leaf, Pau D’Arco and Graviola, among a total of
38 botanical products consumed
Gallbladder and liver detox, cancer prevention,
hormonal health, heart health, parasites, infection, etc.
Flower essences (dilute preparations of flower extracts) For prevention and treatment of multiple ailments
Oil essences (essential oils, used topically, for inhalation or
orally in a dilute form),
For prevention and treatment of multiple ailments
Other non-botanical dietary supplements such as glucosamine sulfate
and essential fatty acids
For prevention and treatment of multiple ailments
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dietary supplements and anticoagulation. Potential inter-
actions include both decreased effectiveness with
increased risk of thromboembolic events or increased
risk of bleeding. Another concern is the potential risk of
mad cow disease with the ingestion of bovine brain
matter (pituitary substance). Clearly, the potential risk of
recurrent thromboembolic event with the substitution of
dietary supplements for warfarin is a concern.
A second issue illustrated here are the role of social
forces in dietary supplement use in the setting of a
dependent adult, who is not capable of making a fully
informed decision. This is not an uncommon problem
and it is truly concerning, not only at the end of life but
it applies as well to the use of supplements in children, by
often well intentioned caretakers who are misinformed
and misguided. The ethical issues represented here are
complex and deserve broader discussion and research.
The third and broader issue illustrated here underlines
the public health problem of unregulated and misin-
formed supplement use. This is an issue of outmost
importance in public policy and education, which needs
urgent attention from scholars, educators and policy
makers. A concerted effort to promote and require
education of health care professionals, CAM providers
and the public in general on scientific evidence pertaining
to safe use of dietary supplements is critical, given the
substantial use of dietary supplements in this country.
Case 4—Fear of Cancer Treatment: Seeking Dietary
Supplements Instead
A 45-year-old woman was referred by her oncologist to
the CAMC with her third recurrence of head and neck
cancer. A regimen of chemo-radiation had been pro-
posed, as the new lesion, albeit very small, was not
resectable due to its proximity to the carotid artery. The
proposed treatment was thought to likely afford her
significant odds of remission and prolonged survival. She
is a single mother with poor social support, and receiving
welfare. She was told by a local health food store owner
that a natural regimen would be her best option
and that she should avoid ‘toxic medical treatment’
at all cost. The patient thus was frightened by the
prospect of side-effects of radiation and chemotherapy
and that her choice to pursue the recommended medical
treatment would ‘prevent her body from healing due to
its inherent toxicity’, as her local health food store owner
advised her (who was not known to be a trained CAM
provider or herbalist). She came to the CAMC to discuss
her treatment options. She estimated monthly cost for the
dietary supplement proposed at over $500a month.
This was beyond her means but she was willing to pay
for that if it would save her life (Table 4).
Comment
Patients are often frightened and vulnerable by learning
of a serious illness, even when that illness is treatable.
They are easily swayed to seeking unproven treatments
while giving up therapies, which have been shown to save
or prolong life. This is often done under the guidance
of unknowledgeable and commonly unlicensed self-
proclaimed healers, who offer the promise of cure
without risks, in contrast with evidence-based risk/benefit
frank discussions of medical treatments. It is important
to notice that the store owner derived significant financial
gain for promoting the large number of supplements to a
vulnerable individual, an often too common ethical
dilemma in the promotion of dietary supplements but
individuals (licensed providers or otherwise) who derive
financial gain from their ‘health advice’. Another issue of
significance here is the serious financial burden created
by uncovered expenses with dietary supplements, to this
socially vulnerable patient. Respectful, knowledgeable
and culturally competent discussions that address the
unmet patient needs (in this case fear, anxiety), often take
place over several visits, and can help the patient
understand the true risk/benefits of both medical and
nonconventional treatments, enabling patients to make a
safer informed decision.
Discussion
The clinical vignettes described in this article highlight
the need for further research on the nature and extent of
Table 3. Dietary supplements and purpose of use
Dietary supplements Purpose of use
Oral Chelation Therapy containing: EDTA,
N-acetyl-cystein, vitamin C, methyl sulfonyl methane
Cleaning of blood vessels
Another supplement product from the same company above
contained multivitamins, minerals, aminoacids, inositol, grape seed extract,
malic acid, PABA, boron, betain HCL, pancreatin, adrenal and thymus
and pituitary substance, buchu leaf, couch grass, garlic powder,
juniper berries and hawthorn berries
Heart and brain health and
blood thinning
Coenzyme Q10 Heart and brain health
Flax seed oil Blood thinning
Cyanocobalamine Nervous system health
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has not been precisely defined in terms of the specific
number of drug products used, the key elements for this
diagnosis are the excessive and inappropriate nature of
medications utilized with increased risk of adverse
drug reactions (1). It has been estimated (4,15) that one
out of every four adults taking prescription medications
are also using dietary supplements concomitantly and
are thus at risk for adverse drug interactions. The
concept of dietary supplement polypharmacy described
above and observed in our practice meets the criteria for
medication polypharmacy. This health care problem is
largely unrecognized and its prevalence among dietary
supplement users is unknown. Based on our clinical
observation coupled with data derived from the national
surveys described above, this problem may be common,
and of considerable public health significance.
Population surveys may have certain limitations, such
as not reaching some respondents who are ill (and thus
possibly more likely to seek alternative remedies), or who
are unwilling to respond to these surveys. Also, many of
these surveys provide somewhat limited lists of common
dietary supplements and may not query the full range of
products being consumed. In some instances, as noted in
our vignettes, multiple constituents are likely to be
included under one product label, which also may not
be captured by the questionnaire. Nor can these surveys
often validate the content of products or provide detailed
lists of their constituents, having often been conducted
by telephone.
Furthermore, in many surveys supplement use is
captured in a single ‘snapshot’ in time, usually in the
past month or year. This information is useful, but may
not capture the frequently changing regimens that some
individuals undertake, as seen in two of our cases.
Our clinical experience suggests sporadic and limited-time
use for many products, at least among some patients.
The details and complexity of dietary supplement use
has escaped the scope of most surveys of dietary
supplement conducted to date. New instruments and
methods may be needed to capture the complexities of
dietary supplement use and its potential clinical and
financial burden (6).
The supplement use patterns described above may be
surprising to some health practitioners. These findings
highlight the need to re-evaluate the format and extent of
clinical history-taking to include the potential for
substantial and diverse supplement use, as well as other
CAM usage. There has been an increasing awareness of
CAM use, and numerous surveys have confirmed this
growing phenomenon (4–6,9) and its clinical and public
health importance (16). Despite this awareness, the
movement to incorporate information on CAM usage
in the medical evaluation (17) and records has been slow,
as has been the professional education (18) oriented
toward preparing physicians to guide patients in the
use of CAM and dietary supplements. The principles
described on each case discussion serve as models for
the practicing physician caring for a patient using
multiple dietary supplements. The counseling principles
discussed after each patient case are summarized
in Table 5.
Limitations and Strengths of the Findings
This report has some limitations requiring discussion,
most relating to generalizability of the patient histories.
The setting of this CAMC experience in a single academic
medical center and geographic area potentially selects
highly interested users of dietary supplements, which may
represent uncommon behaviors when compared with the
general population. Thus, the extent of the consumption
Table 4. Dietary supplements and purpose of use
Dietary supplements Purpose of use
Bowel cleanser: unmarked and unidentified container, given by the health food store Bowel detoxifier
Psyllium
Multivitamin preparation Vitamins, cancer treatment
Vitamin C
Yeast detox: caprylic acid, echinacea, garlic, pau d’arco, slippery elm Clear her body of yeast growth
Candida homeopathy preparation
Super algae containing spirulina; Boost the immune system, detox
pH Green Zone containing algaes spirulina, chlorella and alfalfa
Lymph gland cleanse containing the herbs golden root, yarrow, and parthenium Clean the lymph system
Proactazyme containing the enzymes amylase, lipase, and protease Enzymes, detox, cancer treatment
Protease
E-Tea containing burdock, sheep sorrel, slippery elm Detox, cancer treatment
Coral calcium Cancer treatment, calcium
Pawpaw Cancer treatment
112 Unrecognized Dietary Supplement Polypharmacypatterns described here cannot be extrapolated to the
general population. However, these data include the
details of dietary supplement use, and beliefs and
behaviors regarding that use, not typically captured in
clinical interviewing or national surveys. To our knowl-
edge, there have not been detailed descriptions of
patterns of dietary supplement usage in the indexed
scientific literature.
Conclusion
The hidden and growing phenomenon of dietary supple-
ment polypharmacy adds a new layer of complexity to
patient care and poses a significant public health
problem, still largely unrecognized and poorly under-
stood. There is growing awareness and education to
contain and correct the problem of polypharmacy and its
adverse consequences. Still, despite growing knowledge of
the widespread use of dietary supplements, the health
care profession has yet to assume a concerted effort in
research, education, clinical practice guidelines and public
policy to address this important and growing phenom-
enon. This article attempts to shed some new light on the
practices of dietary supplement use, and highlights the
need for further research as well as consumer and medical
education, in this important area of health care. From a
public policy standpoint, the recent establishment of an
effective post-marketing surveillance and mandatory
reporting mechanism to detect the adverse effects of
dietary supplements (10,16,20) is timely and a step in the
right direction.
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Table 5. Counseling principles
Counseling patients using dietary supplements
1. Ask at each medical visit about the use of dietary supplements.
2. Document details of product ingredients, examine original
product container.
3. If necessary set-up a special encounter to review all supplements used.
4. Evaluate and address unidentified needs such as depression,
anxiety, cost issues.
5. Document dietary supplement use details on medical records.
6. Obtain access to up to date evidence-based information resources
on dietary supplements for entire health care team.
7. Provide counseling on safety, efficacy and potential drug interactions.
8. Report suspected adverse reactions or drug interactions to
MedWatch (16).
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